financetom
Business
financetom
/
Business
/
Costco's Outperformance Case Strengthens Amid Mixed Consumer Spending, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Costco's Outperformance Case Strengthens Amid Mixed Consumer Spending, Oppenheimer Says
Nov 3, 2025 9:53 AM

12:31 PM EST, 11/03/2025 (MT Newswires) -- Costco Wholesale's ( COST ) case for outperformance is now "even stronger" in a mixed consumer spending backdrop, Oppenheimer said in a Monday note, as it reinstated the stock to its Top Pick list.

The brokerage said Costco shares have underperformed year-to-date, down about 1% compared with a 16% gain in the S&P 500. Shares now trade at a relative price-to-earnings ratio of 1.89x, in line with the recent historical average of 1.92x and well below the 2.59x peak earlier this year.

Oppenheimer said Costco remains well-positioned for outperformance, citing its superior value proposition, expected share gains, and exposure to a relatively more affluent customer base.

After visiting a Costco location in New Jersey, the analysts said the retailer appears set to sustain momentum in the non-foods category through products such as consumer electronics, gift cards, branded apparel, and appliances.

Oppenheimer kept the company's stock rating at outperform and adjusted the price target to $1,050 from $1,130 to reflect a re-rating in the space.

Price: 915.89, Change: +4.43, Percent Change: +0.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Abbvie Inc. Reports 9.0 % Passive Stake In Xilio Therapeutics, Inc. As Of Feb 11 - SEC Filing
BRIEF-Abbvie Inc. Reports 9.0 % Passive Stake In Xilio Therapeutics, Inc. As Of Feb 11 - SEC Filing
Feb 18, 2025
Feb 18 (Reuters) - Xilio Therapeutics Inc ( XLO ): * ABBVIE INC. REPORTS 9.0 % PASSIVE STAKE IN XILIO THERAPEUTICS, INC. AS OF FEB 11 - SEC FILING Source text: Further company coverage: ...
Unum Group Board Approves $1 Billion Share Repurchase Program
Unum Group Board Approves $1 Billion Share Repurchase Program
Feb 18, 2025
05:46 PM EST, 02/18/2025 (MT Newswires) -- Unum Group ( UNM ) said late Tuesday that its board approved a $1 billion common stock repurchase program, effective April 1. The board also authorized the termination of the company's current buyback program as of March 31. ...
Saronic Technologies valued at $4 billion after $600 million fundraising
Saronic Technologies valued at $4 billion after $600 million fundraising
Feb 18, 2025
Feb 18 (Reuters) - Saronic Technologies said on Tuesday it has closed a $600 million Series C funding round, led by investor Elad Gil, which valued the autonomous shipbuilding company at $4 billion. The company said it would use the funds to build a new shipyard, called Port Alpha, to expand its autonomous surface vessel fleet into medium and large-class...
Mondelez CEO says Kennedy agenda product re-formulations will mean price hikes
Mondelez CEO says Kennedy agenda product re-formulations will mean price hikes
Feb 18, 2025
ORLANDO, Feb 18 (Reuters) - Mondelez ( MDLZ ) CEO Dirk van de Put on Tuesday said the Oreo maker will face new cost pressures from the Make America Healthy Again movement spearheaded by U.S. health secretary Robert F. Kennedy Jr and that Americans would see price hikes. Make America Healthy Again could require that Mondelez ( MDLZ ) reformulate...
Copyright 2023-2026 - www.financetom.com All Rights Reserved